Merck CEO Robert Davis joins ‘Squawk Box’ to discuss the company’s quarterly earnings results, which topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business, the company’s drug pipeline outlook, and more.
Source link
